Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
NUTX · against 596 other Healthcare companies listed in US-listed
Ranked #426 of 597 · scores higher than 29% of peers · safety percentile 20
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)59 peers with a safety percentile of 20–29, including NUTX · Click a bar to see the companies
Mainly because of its beta and debt / equity, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | NUTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 523 reported | 0.68× | 0.23× | 30% | 33% | |
| BetaLower is better · 556 reported | 2.00 | 0.95 | 10% | 33% | |
| Current ratioHigher is better · 600 reported | 5.00× | 3.91× | 58% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 422 | 45.9B USD | 21 | 61 | |
| 423 | 2.0B USD | 21 | 29 | |
| 424 | 97.5B USD | 20 | 67 | |
| 425 | 1.4B USD | 20 | 42 | |
| 426 | 1.2B USD | 20 | 75 | |
| 427 | 31.3B USD | 20 | 63 | |
| 428 | 13.3B USD | 20 | 59 | |
| 429 | 66.3B USD | 20 | 30 | |
| 430 | 234M USD | 19 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score